Index by author
January 01, 2004; Volume 32,Issue 1
A
Akasawa, Akira
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Akimoto, Masayuki
- You have accessCATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATIONIzumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan ChibaDrug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7
Alipour, Masumeh
- You have accessCYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTORSarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. KocarekDrug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66
Ang, Catharina Y.W.
- You have accessIN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMSYanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian LeakeyDrug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28
Arai, Masayuki
- You have accessCATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATIONIzumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan ChibaDrug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7
B
Basly, Jean-Philippe
- You have accessMETABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVERAngéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline TeyssierDrug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58
Beger, Richard D.
- You have accessIN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMSYanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian LeakeyDrug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28
Blanchard, Andrew P.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Brocks, D.R.
- You have accessSUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATSJ. Kalitsky-Szirtes, A. Shayeganpour, D.R. Brocks and M. Piquette-MillerDrug Metabolism and Disposition January 2004, 32 (1) 20-27; DOI: https://doi.org/10.1124/dmd.32.1.20
Broudy, Marc I.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Brunengraber, Henri
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Brunengraber, Laura L.
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
C
Canivenc-Lavier, Marie-Chantal
- You have accessMETABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVERAngéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline TeyssierDrug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58
Cargill, Catherine E.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Chen, Cuiping
- You have accessDEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITYXingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. SmithDrug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132
Chiba, Kan
- You have accessCATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATIONIzumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan ChibaDrug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7
Comte, Blandine
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Crespi, Charles L.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Crews, Brenda C.
- You have accessSTUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITESRory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. MarnettDrug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113
Cui, Yanyan
- You have accessIN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMSYanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian LeakeyDrug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28
D
Dahms, William
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Dalvie, Deepak K.
- You have accessCHARACTERIZATION OF NOVEL DIHYDROTHIENOPYRIDINIUM AND THIENOPYRIDINIUM METABOLITES OF TICLOPIDINE IN VITRO: ROLE OF PEROXIDASES, CYTOCHROMES P450, AND MONOAMINE OXIDASESDeepak K. Dalvie and Thomas N. O'ConnellDrug Metabolism and Disposition January 2004, 32 (1) 49-57; DOI: https://doi.org/10.1124/dmd.32.1.49
Dandeneau, Andre A.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
David, France
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Dehal, Shangara S.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
DeMarini, David M.
- You have accessMETABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANERogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. EvansDrug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123
Doerge, Daniel R.
- You have accessCHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip LazarusDrug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72
Doss, George A.
- You have accessN-ACETYLATION OF THE GLUTAMATE RESIDUE OF INTACT GLUTATHIONE CONJUGATES IN RATS: A NOVEL PATHWAY FOR THE METABOLIC PROCESSING OF THIOL ADDUCTS OF XENOBIOTICSWenji Yin, George A. Doss, Ralph A. Stearns and Sanjeev KumarDrug Metabolism and Disposition January 2004, 32 (1) 43-48; DOI: https://doi.org/10.1124/dmd.32.1.43
E
Eckett, Nina
- You have accessTHE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURELydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick MaurelDrug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80
Eckstein, James A.
- You have accessAN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTESMatthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. WrightonDrug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140
Erve, John C. L.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Evans, Marina V.
- You have accessMETABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANERogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. EvansDrug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123
F
Fabre, Jean-Michel
- You have accessTHE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURELydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick MaurelDrug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80
Fang, Jia-Long
- You have accessCHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip LazarusDrug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72
G
Gargano, Mary D.
- You have accessCYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTORSarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. KocarekDrug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66
Goodwin, Joseph J.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Gradolatto, Angéline
- You have accessMETABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVERAngéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline TeyssierDrug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58
Granville, Courtney
- You have accessMETABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANERogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. EvansDrug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123
H
Halpert, James R.
- You have accessTOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESISYoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. HalpertDrug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155
Hasegawa, Ryuichi
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
He, You Ai
- You have accessTOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESISYoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. HalpertDrug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155
He, You Qun
- You have accessTOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESISYoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. HalpertDrug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155
Hebbel, Robert P.
- You have accessMETABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICESwati Nagar, Rory P. Remmel, Robert P. Hebbel and Cheryl L. ZimmermanDrug Metabolism and Disposition January 2004, 32 (1) 98-104; DOI: https://doi.org/10.1124/dmd.32.1.98
Heinze, Thomas M.
- You have accessIN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMSYanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian LeakeyDrug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28
Higuchi, Shohei
- You have accessCATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATIONIzumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan ChibaDrug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7
Hirota, Mitsuyo
- You have accessCATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATIONIzumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan ChibaDrug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7
Ho, Thuy
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Hu, Lihong
- You have accessIN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMSYanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian LeakeyDrug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28
I
Iida, Izumi
- You have accessCATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATIONIzumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan ChibaDrug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7
J
Jobbins, Kathryn
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Jones, Jeffrey P.
- You have accessMETABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANERogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. EvansDrug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123
K
Kalgutkar, Amit S.
- You have accessSTUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITESRory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. MarnettDrug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113
Kalitsky-Szirtes, J.
- You have accessSUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATSJ. Kalitsky-Szirtes, A. Shayeganpour, D.R. Brocks and M. Piquette-MillerDrug Metabolism and Disposition January 2004, 32 (1) 20-27; DOI: https://doi.org/10.1124/dmd.32.1.20
Kamakura, Shiro
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Kasper, Steve C.
- You have accessAN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTESMatthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. WrightonDrug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140
Kasumov, Takhar
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Kelly, Rebecca S.
- You have accessDEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITYXingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. SmithDrug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132
Kerr, Douglas
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Khan, Kishore K.
- You have accessTOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESISYoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. HalpertDrug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155
Kinman, Renee
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Kitakaze, Masafumi
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Kobayashi, Kaoru
- You have accessCATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATIONIzumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan ChibaDrug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7
Kocarek, Thomas A.
- You have accessCYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTORSarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. KocarekDrug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66
Komamura, Kazuo
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Koyano, Satoru
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Kozak, Kevin R.
- You have accessSTUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITESRory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. MarnettDrug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113
Kumar, Sanjeev
- You have accessN-ACETYLATION OF THE GLUTAMATE RESIDUE OF INTACT GLUTATHIONE CONJUGATES IN RATS: A NOVEL PATHWAY FOR THE METABOLIC PROCESSING OF THIOL ADDUCTS OF XENOBIOTICSWenji Yin, George A. Doss, Ralph A. Stearns and Sanjeev KumarDrug Metabolism and Disposition January 2004, 32 (1) 43-48; DOI: https://doi.org/10.1124/dmd.32.1.43
Kurose, Kouichi
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
L
Laskey, John
- You have accessMETABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANERogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. EvansDrug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123
Lazarus, Philip
- You have accessCHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip LazarusDrug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72
Leakey, Julian
- You have accessIN VITRO METABOLISM OF HYPERFORIN IN RAT LIVER MICROSOMAL SYSTEMSYanyan Cui, Catharina Y.W. Ang, Richard D. Beger, Thomas M. Heinze, Lihong Hu and Julian LeakeyDrug Metabolism and Disposition January 2004, 32 (1) 28-34; DOI: https://doi.org/10.1124/dmd.32.1.28
Li, Yuxin
- You have accessTHE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENESXiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang YanDrug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35
Liu, Xingrong
- You have accessDEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITYXingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. SmithDrug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132
Lucas, Catherine
- You have accessTHE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURELydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick MaurelDrug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80
M
Marnett, Lawrence J.
- You have accessSTUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITESRory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. MarnettDrug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113
Matsumoto, Kenji
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Maurel, Patrick
- You have accessTHE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURELydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick MaurelDrug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80
Mercer-Haines, Nancy A.
- You have accessCYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTORSarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. KocarekDrug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66
Miyata, Atsunori
- You have accessCATALYTIC ROLES OF CYP2C9 AND ITS VARIANTS (CYP2C9*2 AND CYP2C9*3) IN LORNOXICAM 5′-HYDROXYLATIONIzumi Iida, Atsunori Miyata, Masayuki Arai, Mitsuyo Hirota, Masayuki Akimoto, Shohei Higuchi, Kaoru Kobayashi and Kan ChibaDrug Metabolism and Disposition January 2004, 32 (1) 7-9; DOI: https://doi.org/10.1124/dmd.32.1.7
N
Nagar, Swati
- You have accessMETABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICESwati Nagar, Rory P. Remmel, Robert P. Hebbel and Cheryl L. ZimmermanDrug Metabolism and Disposition January 2004, 32 (1) 98-104; DOI: https://doi.org/10.1124/dmd.32.1.98
Nakajima, Toshiharu
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Nissim, Itzhak
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
O
O'Connell, Thomas N.
- You have accessCHARACTERIZATION OF NOVEL DIHYDROTHIENOPYRIDINIUM AND THIENOPYRIDINIUM METABOLITES OF TICLOPIDINE IN VITRO: ROLE OF PEROXIDASES, CYTOCHROMES P450, AND MONOAMINE OXIDASESDeepak K. Dalvie and Thomas N. O'ConnellDrug Metabolism and Disposition January 2004, 32 (1) 49-57; DOI: https://doi.org/10.1124/dmd.32.1.49
Obach, R. Scott
- You have accessPOTENT INHIBITION OF HUMAN LIVER ALDEHYDE OXIDASE BY RALOXIFENER. Scott ObachDrug Metabolism and Disposition January 2004, 32 (1) 89-97; DOI: https://doi.org/10.1124/dmd.32.1.89
Ozawa, Shogo
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
P
Patten, Christopher J.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Petullo, David M.
- You have accessAN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTESMatthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. WrightonDrug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140
Pichard-Garcia, Lydiane
- You have accessTHE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURELydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick MaurelDrug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80
Piquette-Miller, M.
- You have accessSUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATSJ. Kalitsky-Szirtes, A. Shayeganpour, D.R. Brocks and M. Piquette-MillerDrug Metabolism and Disposition January 2004, 32 (1) 20-27; DOI: https://doi.org/10.1124/dmd.32.1.20
Porter, Todd D.
- You have accessJUD COON: 35 YEARS OF P450 RESEARCH, A SYNOPSIS OF P450 HISTORYTodd D. PorterDrug Metabolism and Disposition January 2004, 32 (1) 1-6; DOI: https://doi.org/10.1124/dmd.32.1.1
Puchowicz, Michelle A.
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
R
Remmel, Rory P.
- You have accessSTUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITESRory P. Remmel, Brenda C. Crews, Kevin R. Kozak, Amit S. Kalgutkar and Lawrence J. MarnettDrug Metabolism and Disposition January 2004, 32 (1) 113-122; DOI: https://doi.org/10.1124/dmd.32.1.113
- You have accessMETABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICESwati Nagar, Rory P. Remmel, Robert P. Hebbel and Cheryl L. ZimmermanDrug Metabolism and Disposition January 2004, 32 (1) 98-104; DOI: https://doi.org/10.1124/dmd.32.1.98
Ross, Matthew K.
- You have accessMETABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANERogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. EvansDrug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123
Runge-Morris, Melissa
- You have accessCYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTORSarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. KocarekDrug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66
S
Sachdeva, Karuna
- You have accessTHE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENESXiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang YanDrug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35
Saito, Hirohisa
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Saito, Yoshiro
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Sawada, Jun-Ichi
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Scarfe, Graeme
- You have accessTHE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURELydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick MaurelDrug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80
Sharma, Raman
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
Shayeganpour, A.
- You have accessSUPPRESSION OF DRUG-METABOLIZING ENZYMES AND EFFLUX TRANSPORTERS IN THE INTESTINE OF ENDOTOXIN-TREATED RATSJ. Kalitsky-Szirtes, A. Shayeganpour, D.R. Brocks and M. Piquette-MillerDrug Metabolism and Disposition January 2004, 32 (1) 20-27; DOI: https://doi.org/10.1124/dmd.32.1.20
Shenoy, Sarita D.
- You have accessCYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTORSarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. KocarekDrug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66
Siess, Marie-Hélène
- You have accessMETABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVERAngéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline TeyssierDrug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58
Smith, Bill J.
- You have accessDEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITYXingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. SmithDrug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132
Soars, Matthew G.
- You have accessAN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTESMatthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. WrightonDrug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140
Song, Xiulong
- You have accessTHE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENESXiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang YanDrug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35
Spencer, Thomas A.
- You have accessCYP3A INDUCTION BY LIVER X RECEPTOR LIGANDS IN PRIMARY CULTURED RAT AND MOUSE HEPATOCYTES IS MEDIATED BY THE PREGNANE X RECEPTORSarita D. Shenoy, Thomas A. Spencer, Nancy A. Mercer-Haines, Masumeh Alipour, Mary D. Gargano, Melissa Runge-Morris and Thomas A. KocarekDrug Metabolism and Disposition January 2004, 32 (1) 66-71; DOI: https://doi.org/10.1124/dmd.32.1.66
Stearns, Ralph A.
- You have accessN-ACETYLATION OF THE GLUTAMATE RESIDUE OF INTACT GLUTATHIONE CONJUGATES IN RATS: A NOVEL PATHWAY FOR THE METABOLIC PROCESSING OF THIOL ADDUCTS OF XENOBIOTICSWenji Yin, George A. Doss, Ralph A. Stearns and Sanjeev KumarDrug Metabolism and Disposition January 2004, 32 (1) 43-48; DOI: https://doi.org/10.1124/dmd.32.1.43
Stresser, David M.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
T
Teyssier, Caroline
- You have accessMETABOLISM OF APIGENIN BY RAT LIVER PHASE I AND PHASE II ENZYMES AND BY ISOLATED PERFUSED RAT LIVERAngéline Gradolatto, Marie-Chantal Canivenc-Lavier, Jean-Philippe Basly, Marie-Hélène Siess and Caroline TeyssierDrug Metabolism and Disposition January 2004, 32 (1) 58-65; DOI: https://doi.org/10.1124/dmd.32.1.58
Thomas, Katherine
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Tornero-Velez, Rogelio
- You have accessMETABOLISM AND MUTAGENICITY OF SOURCE WATER CONTAMINANTS 1,3-DICHLOROPROPANE AND 2,2-DICHLOROPROPANERogelio Tornero-Velez, Matthew K. Ross, Courtney Granville, John Laskey, Jeffrey P. Jones, David M. DeMarini and Marina V. EvansDrug Metabolism and Disposition January 2004, 32 (1) 123-131; DOI: https://doi.org/10.1124/dmd.32.1.123
Tu, Meihua
- You have accessDEVELOPMENT OF A COMPUTATIONAL APPROACH TO PREDICT BLOOD-BRAIN BARRIER PERMEABILITYXingrong Liu, Meihua Tu, Rebecca S. Kelly, Cuiping Chen and Bill J. SmithDrug Metabolism and Disposition January 2004, 32 (1) 132-139; DOI: https://doi.org/10.1124/dmd.32.1.132
Turner, Stephanie D.
- You have accessHIGHLY SELECTIVE INHIBITION OF HUMAN CYP3A IN VITRO BY AZAMULIN AND EVIDENCE THAT INHIBITION IS IRREVERSIBLEDavid M. Stresser, Marc I. Broudy, Thuy Ho, Catherine E. Cargill, Andrew P. Blanchard, Raman Sharma, Andre A. Dandeneau, Joseph J. Goodwin, Stephanie D. Turner, John C. L. Erve, Christopher J. Patten, Shangara S. Dehal and Charles L. CrespiDrug Metabolism and Disposition January 2004, 32 (1) 105-112; DOI: https://doi.org/10.1124/dmd.32.1.105
U
Ueno, Kazuyuki
- You have accessFUNCTIONAL CHARACTERIZATION OF FOUR NATURALLY OCCURRING VARIANTS OF HUMAN PREGNANE X RECEPTOR (PXR): ONE VARIANT CAUSES DRAMATIC LOSS OF BOTH DNA BINDING ACTIVITY AND THE TRANSACTIVATION OF THE CYP3A4 PROMOTER/ENHANCER REGIONSatoru Koyano, Kouichi Kurose, Yoshiro Saito, Shogo Ozawa, Ryuichi Hasegawa, Kazuo Komamura, Kazuyuki Ueno, Shiro Kamakura, Masafumi Kitakaze, Toshiharu Nakajima, Kenji Matsumoto, Akira Akasawa, Hirohisa Saito and Jun-Ichi SawadaDrug Metabolism and Disposition January 2004, 32 (1) 149-154; DOI: https://doi.org/10.1124/dmd.32.1.149
Upadhyaya, Pramod
- You have accessCHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip LazarusDrug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72
W
Weaver, Richard John
- You have accessTHE OLIVACINE DERIVATIVE S 16020 (9-HYDROXY-5,6-DIMETHYL-N-[2-(DIMETHYLAMINO)ETHYL)-6H-PYRIDO(4,3-B)-CARBAZOLE-1-CARBOXAMIDE) INDUCES CYP1A AND ITS OWN METABOLISM IN HUMAN HEPATOCYTES IN PRIMARY CULTURELydiane Pichard-Garcia, Richard John Weaver, Nina Eckett, Graeme Scarfe, Jean-Michel Fabre, Catherine Lucas and Patrick MaurelDrug Metabolism and Disposition January 2004, 32 (1) 80-88; DOI: https://doi.org/10.1124/dmd.32.1.80
Wehrli, Suzanne
- You have accessNEW SECONDARY METABOLITES OF PHENYLBUTYRATE IN HUMANS AND RATSTakhar Kasumov, Laura L. Brunengraber, Blandine Comte, Michelle A. Puchowicz, Kathryn Jobbins, Katherine Thomas, France David, Renee Kinman, Suzanne Wehrli, William Dahms, Douglas Kerr, Itzhak Nissim and Henri BrunengraberDrug Metabolism and Disposition January 2004, 32 (1) 10-19; DOI: https://doi.org/10.1124/dmd.32.1.10
Wiener, Doris
- You have accessCHARACTERIZATION OF N-GLUCURONIDATION OF THE LUNG CARCINOGEN 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANOL (NNAL) IN HUMAN LIVER: IMPORTANCE OF UDP-GLUCURONOSYLTRANSFERASE 1A4Doris Wiener, Daniel R. Doerge, Jia-Long Fang, Pramod Upadhyaya and Philip LazarusDrug Metabolism and Disposition January 2004, 32 (1) 72-79; DOI: https://doi.org/10.1124/dmd.32.1.72
Wrighton, Steven A.
- You have accessAN ASSESSMENT OF UDP-GLUCURONOSYLTRANSFERASE INDUCTION USING PRIMARY HUMAN HEPATOCYTESMatthew G. Soars, David M. Petullo, James A. Eckstein, Steve C. Kasper and Steven A. WrightonDrug Metabolism and Disposition January 2004, 32 (1) 140-148; DOI: https://doi.org/10.1124/dmd.32.1.140
X
Xie, Mingxing
- You have accessTHE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENESXiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang YanDrug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35
Y
Yamaguchi, Yoshitaka
- You have accessTOPOLOGICAL CHANGES IN THE CYP3A4 ACTIVE SITE PROBED WITH PHENYLDIAZENE: EFFECT OF INTERACTION WITH NADPH-CYTOCHROME P450 REDUCTASE AND CYTOCHROME B5 AND OF SITE-DIRECTED MUTAGENESISYoshitaka Yamaguchi, Kishore K. Khan, You Ai He, You Qun He and James R. HalpertDrug Metabolism and Disposition January 2004, 32 (1) 155-161; DOI: https://doi.org/10.1124/dmd.32.1.155
Yan, Bingfang
- You have accessTHE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENESXiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang YanDrug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35
Yin, Wenji
- You have accessN-ACETYLATION OF THE GLUTAMATE RESIDUE OF INTACT GLUTATHIONE CONJUGATES IN RATS: A NOVEL PATHWAY FOR THE METABOLIC PROCESSING OF THIOL ADDUCTS OF XENOBIOTICSWenji Yin, George A. Doss, Ralph A. Stearns and Sanjeev KumarDrug Metabolism and Disposition January 2004, 32 (1) 43-48; DOI: https://doi.org/10.1124/dmd.32.1.43
Z
Zhang, He
- You have accessTHE PREGNANE X RECEPTOR BINDS TO RESPONSE ELEMENTS IN A GENOMIC CONTEXT-DEPENDENT MANNER, AND PXR ACTIVATOR RIFAMPICIN SELECTIVELY ALTERS THE BINDING AMONG TARGET GENESXiulong Song, Mingxing Xie, He Zhang, Yuxin Li, Karuna Sachdeva and Bingfang YanDrug Metabolism and Disposition January 2004, 32 (1) 35-42; DOI: https://doi.org/10.1124/dmd.32.1.35
Zimmerman, Cheryl L.
- You have accessMETABOLISM OF OPIOIDS IS ALTERED IN LIVER MICROSOMES OF SICKLE CELL TRANSGENIC MICESwati Nagar, Rory P. Remmel, Robert P. Hebbel and Cheryl L. ZimmermanDrug Metabolism and Disposition January 2004, 32 (1) 98-104; DOI: https://doi.org/10.1124/dmd.32.1.98